Merge Hemo software — Class II medical device recall Z-1457-2017
Terminated recall by Merge Healthcare, Inc., reported 2017-03-22, distributed nationwide. In some instances, the system will lock tabs within a study, even when a second user does not have the study o
| Recall number | Z-1457-2017 |
|---|---|
| Product type | Medical device |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Merge Healthcare, Inc., Hartland, WI, United States |
| Recall initiated | 2016-04-04 |
| Classified | 2017-03-13 |
| Reported by FDA | 2017-03-22 |
| Terminated | 2019-08-05 |
| Distributed | Nationwide (US) |
| Quantity | 361 sites |
Product
Merge Hemo software. Product Usage: Merge Hemo is a hemodynamic monitoring system that records and displays physiological data.
Reason for recall
In some instances, the system will lock tabs within a study, even when a second user does not have the study open on a different workstation.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-1457-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.